At the intersection of immunology and genetics, working to advance our understanding of B-cell biology and oncohematological disease. Lead by Dr Sergio Roa
Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL. https://t.co/yxqAl5cdkD #immunobiologyandimmunotherapy#lymphoidneoplasia
ONLY 2 weeks left to apply for the #postdocjob in my lab!
If you crave for a collaborative #team to pursue 🔥 #research at the crossroad between #Genome Diversification & Stability, #immunity & #carcinogenesis... WE ARE LOOKING FOR YOU!!!! 😎
Apply 👇 or kindly RT
Happy to share our publication in Journal for Immunotherapy of Cancer @jitcancer, a collaborative effort at @unav,@CIMA_unav,@idisnanavarra,@CIBERONC,imCORE @Roche.
Using preclinical models to explore novel immunotherapy combinations for B-cell lymphoma https://t.co/LKk9mXJb9X
📢 Freno a la inflamación que favorece al cáncer
Un trabajo coordinado por @DrIgMelero y publicado en el último número de @CD_AACR
https://t.co/v7xydk2YBm
Congratulations to our @Einstein_SCI Interim Director Uli Steidl @SteidlUli for his appointment as the new president of the @ISEHSociety! As a phenomenal #ISEH2022 meeting comes to a close, we are very much looking forward to #ISEH2023 in New York City!
Indeed, team persistance over the years @EinsteinMed@Unispital_USZ and @unav, with key collaborators in USA and Europe.
EXO1 is more than "just" its exonuclease activity during antibody diversification or meiosis. Check out our recent publication in @NAR_Open to learn more...
Finally out! Our collaborative work to identify the 3-tiered role of EXO1 in DDR, immune diversity, tumorigenesis, and meiosis. https://t.co/K1fWXrtZ0p
Great meeting in Quebec City, commemorating 20+2 years of chasing AID and its role in immunity and cancer. Amazing reunion of research colleagues and friends thanks to @jmdinoia @albertoxmartin@langlois_ma & R Pezo.
Thank you @carovinuesa and Yuke He for highlighting our study (@AdiBiram) in the @ImmunityCP Preview section. And thank you for choosing our picture for the journal cover!!
Monocytes asphyxiate germinal centers: Immunity https://t.co/ZdGoA8FKF6
Check out our latest Review in @Cancers_MDPI.
Our group aims to better understand "The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas"
https://t.co/babCZL473b @unav@cienciasunav@CIMA_unav
La #Inmunología, una especialidad clave que sigue ganando reconocimiento.
El #ISCIIII y la @SEinmunologia han celebrado una jornada científica en este Día Internacional de la Inmunología.
📰 Resumen #NoticiasISCIII ➡️
https://t.co/6K8UZuz8jJ
📹Vídeo ➡️ https://t.co/jhxVpkfczF
Comienza la jornada científica online organizada por el #ISCIII y la @SEinmunologia en el del Día Internacional de la #Inmunología.
Presentan Isabel Cortegano y Pilar Lauzurica, del Área de Inmunología del Centro Nacional de Microbiología.
En directo ⬇️ https://t.co/GlWlRLPrxi
Un estudio molecular coordinado por nuestra investigadora @StubbsHervas acerca el tratamiento personalizado a las pacientes con #cáncerdeovario https://t.co/hHZZfKlVFw
La Dra. Sandra Hervás, (@CIMA_unav ) con el apoyo de la @aecc_es , descifra una manera de potenciar el efecto de la inmunoterapia en pacientes de cáncer de ovario para acabar con estos tumores. #InvestigarEsAvanzar https://t.co/wsbgh5VwnU